Author:
Figueroa-Casas P. R.,Romagnoli M.,Mirkin A.
Reference5 articles.
1. Del Pozo, E., Vargas, L., Wiss, H., Tolis, G., Friesen, H., Wenner, R., Vetter, L. and Uttwiler, A. (1974). Clinical and hormonal response to bromocriptine (CB-154) in the galactorrhea syndrome. J. Clin. Endocrinol. Metab., 39, 18
2. Badano, A. R., Miechi, H. R., Mirkin, A., Arcángeli, O. A., Aparicio, N. J., Rodríguez, A., Oliva, A., Turner, D. and Figueroa Casas, P. R. (1979). Bromocriptine in the treatment of hyperprolactinemic amenorrhea. Fertil. Steril., 31, 2
3. Rjosk, H. K., Fahlbusch, R. and Von Wender, K. (1982). Spontaneous development of hyperprolactinemia. Acta Endocrinol., 100, 333
4. March, C. M., Kletzky, O. A., Davajan, V., Teal, J., Weiss, M., Apuzzo, M. L. J., Marrs, R. P. and Mishell, D. R. (1981). Longitudinal evaluation of patients with untreated prolactin secreting pituitary adenomas. Am. J. Obstet. Gynecol., 139, 835
5. Koppelman, M. C. S., Jaffey, M. J., Rieth, K. G., Caruso, R. C. and Loriaux, D. L. (1982). The natural history of hyperprolactinemia, galactorrhea, and amenorrhoea. Fertil. News, 5, 2